| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/24/2008 | WO2008157789A2 Rational design of binding proteins that recognize desired specific squences |
| 12/24/2008 | WO2008157729A2 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 12/24/2008 | WO2008157572A2 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 12/24/2008 | WO2008157559A2 Generation of plants with altered oil, protein or fiber content |
| 12/24/2008 | WO2008157459A2 Methods and systems for identifying molecular pathway elements |
| 12/24/2008 | WO2008157432A1 Polynucleotides and methods for making plants resistant to fungal pathogens |
| 12/24/2008 | WO2008157419A2 Immunogenic peptides of influenza virus |
| 12/24/2008 | WO2008157375A1 Nitrate reductases from porphyra, compositions and methods of use thereof |
| 12/24/2008 | WO2008157370A2 Secondary wall forming genes from maize and uses thereof |
| 12/24/2008 | WO2008157367A1 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor |
| 12/24/2008 | WO2008157350A2 Methods and materials for reducing biofilms |
| 12/24/2008 | WO2008157316A1 Improved method for rna isolation |
| 12/24/2008 | WO2008157136A1 Chimeric sle/dengue type 4 antigenic viruses |
| 12/24/2008 | WO2008156702A2 Bacteria mediated gene silencing |
| 12/24/2008 | WO2008156668A1 Transgenic mammals that produce exogenous proteins in milk |
| 12/24/2008 | WO2008156661A2 BACTERIAL MEDIATED TNF-α GENE SILENCING |
| 12/24/2008 | WO2008156551A2 Tat signal peptides for producing proteins in prokaryotes |
| 12/24/2008 | WO2008156500A2 Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells |
| 12/24/2008 | WO2008156214A1 Rose containing flavone and delphinidin, and method for production thereof |
| 12/24/2008 | WO2008156211A1 Rose containing flavone, and method for production thereof |
| 12/24/2008 | WO2008156206A1 Rose containing flavone and malvidin, and method for production thereof |
| 12/24/2008 | WO2008156172A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008156048A1 Set of yeast cells, method of identifying target candidate molecule, method of analyzing action mechanism and screening method |
| 12/24/2008 | WO2008156026A1 Glycerol-3-phosphate acyltransferase (gpat) homologue and use thereof |
| 12/24/2008 | WO2008156021A1 Method for introducing foreign substance into cell having cell wall |
| 12/24/2008 | WO2008156012A1 CANCER REMEDY CONTAINING MORTALIN siRNA |
| 12/24/2008 | WO2008155924A1 Glucose dehydrogenase |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155509A2 Modified human factor vii/viia and pharmaceutical composition containing same |
| 12/24/2008 | WO2008155397A2 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
| 12/24/2008 | WO2008155306A1 Nucleic acid constructs for the inactivation and conditional mutagenesis of genes |
| 12/24/2008 | WO2008155304A1 Synthetic repetitive proteins, the production and use thereof |
| 12/24/2008 | WO2008155139A2 Methods and means for the production of plants with improved stress resistance |
| 12/24/2008 | WO2008155134A1 Biological active proteins having increased in vivo and/or vitro stability |
| 12/24/2008 | WO2008155122A1 Targeted provision of recombinase activity by trans-splicing |
| 12/24/2008 | WO2008155120A2 Methods and compositions for treating mucositis |
| 12/24/2008 | WO2008154868A1 Capsid proteins and uses therefore |
| 12/24/2008 | WO2008154867A1 Material with immunogenicity |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008154813A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 12/24/2008 | WO2008154719A1 Recombinant human interferon-like proteins |
| 12/24/2008 | WO2008154695A1 Method for improving stress resistance in plants and materials therefor |
| 12/24/2008 | WO2008134464A3 Sample-processing reagent compositions, methods, and devices |
| 12/24/2008 | WO2008134461A3 Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| 12/24/2008 | WO2008131006A3 Method for inhibiting scavenger receptor-a and increasing immune response to antigens |
| 12/24/2008 | WO2008124119A9 Improved methods and compositions for determining the pathogenic status of infectious agents |
| 12/24/2008 | WO2008124086A3 Chimeric activators: quantitatively designed protein therapeutics and uses thereof |
| 12/24/2008 | WO2008115185A3 Use of microarrays for genomic representation selection |
| 12/24/2008 | WO2008113773A3 Gene expression regulation technology and noncoding rnas for diagnosis and therapy |
| 12/24/2008 | WO2008112628A3 Preparation and use of plant embryo explants for transformation |
| 12/24/2008 | WO2008109547A9 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof |
| 12/24/2008 | WO2008109487A9 Nucleic acid compounds for inhibiting mme gene expression and uses thereof |
| 12/24/2008 | WO2008109469A3 Nucleic acid compounds for inhibiting pcna gene expression and uses thereof |
| 12/24/2008 | WO2008108890A3 Conditionally replicating viruses for cancer therapy |
| 12/24/2008 | WO2008103135A3 The micrornaome |
| 12/24/2008 | WO2008101234A8 Anti ganglioside gd3 antibodies and uses thereof |
| 12/24/2008 | WO2008100470A3 Rage - immunoglobulin fusion proteins |
| 12/24/2008 | WO2008084410A3 Human cytomegalovirus neutralising antibodies and use thereof |
| 12/24/2008 | WO2008080003A3 Generation of oncolytic adenoviruses and uses thereof |
| 12/24/2008 | WO2008076487A3 Antibodies and methods for making and using them |
| 12/24/2008 | WO2008073615A9 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 12/24/2008 | WO2008067526A3 Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers |
| 12/24/2008 | WO2008067043A3 Soybean gene for resistance to aphis glycines |
| 12/24/2008 | WO2008060941A3 Expression system of nell peptide |
| 12/24/2008 | WO2008039450A3 Designer organisms for photosynthetic production of ethanol from carbon dioxide and water |
| 12/24/2008 | WO2008030611A3 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 12/24/2008 | WO2008030449A3 Plants with altered carbon allocation |
| 12/24/2008 | WO2008021223A3 System, method, and device for the expression or repression of proteins |
| 12/24/2008 | WO2008019368A3 Albumin-insulin fusion proteins |
| 12/24/2008 | WO2008008844A3 Mpo1 gene and protein and methods of use |
| 12/24/2008 | WO2008008553A3 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 12/24/2008 | WO2007147159A3 Functional nucleic acid ligands to fluorescent proteins |
| 12/24/2008 | WO2007143354A3 Switchable photosystem-ii designer algae for photobiological hydrogen production |
| 12/24/2008 | WO2007132193A8 Modified vird2 protein and its use in improved gene transfer |
| 12/24/2008 | WO2007126850A3 Photoperiodic control of floret differentiation and yield in plants |
| 12/24/2008 | WO2007109097A3 RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF |
| 12/24/2008 | WO2007092453A3 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 12/24/2008 | WO2007047766A3 Methods for rejuvenating cells in vitro and in vivo |
| 12/24/2008 | WO2006088597A3 A plasmodium vivax hybrid circumsporozoite protein and vaccine |
| 12/24/2008 | WO2006078680A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 12/24/2008 | WO2006065933A3 Oxygen-controlled environment for cell- and tissue culture |
| 12/24/2008 | WO2006009649A3 Brassica indehiscent1 sequences |
| 12/24/2008 | EP2006683A1 Human megalin determination method |
| 12/24/2008 | EP2006679A2 Biochip substrate and biochip |
| 12/24/2008 | EP2006395A1 Molecular differences between species of the M. tuberculosis complex |
| 12/24/2008 | EP2006391A1 Method for production of carboxylic acid using methanol-utilizing bacterium |
| 12/24/2008 | EP2006388A1 Nucleic acid constructs for deactivation and conditional mutagenesis of genes |
| 12/24/2008 | EP2006387A1 Translation control elements for plastid transformation |
| 12/24/2008 | EP2006386A1 Process for the preparation of L-amino acids using strains of the Enterobacteriaceae family |
| 12/24/2008 | EP2006385A2 Limnanthes oil genes |
| 12/24/2008 | EP2006384A1 Preprocalcitonin-derived antigen epitopes |
| 12/24/2008 | EP2006382A1 Dopamine-producing neuron progenitor cell marker 187a5 |
| 12/24/2008 | EP2006381A1 Method for control of blood kinetics of antibody |
| 12/24/2008 | EP2006380A1 Agonistic antibody directed against human thrombopoietin receptor |
| 12/24/2008 | EP2006379A1 High functional bispecific antibody |
| 12/24/2008 | EP2006378A1 Novel beta-galactoside alpha- 2,6-sialyltransferase, gene coding for the transferase and process for producing the same |
| 12/24/2008 | EP2006377A2 Novel tumor antigen peptides |
| 12/24/2008 | EP2006375A2 Panel cell used for granulocyte antibody detection |
| 12/24/2008 | EP2006305A2 Modified antibody with enhanced bioactivity |